Evidence map›Paper›PMID 20516076›Full record

ArticleThe Journal of biological chemistry2010

Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator.

Helen J Brown, Li Peng, Josephine N Harada, John R Walker, Steven Cole, Su-Fang Lin, Jerome A Zack, Sumit K Chanda, Ren Sun

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Daily heart rate variability biofeedback training decreases locus coeruleus MRI contrast in younger adults in a randomized clinical trial.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2023
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Helen J BrownDepartment of Microbiology, Division of Hematology-Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA. hjbrown@mednet.ucla.edu
Li Peng
Josephine N Harada
John R Walker
Steven Cole
Su-Fang Lin
Jerome A Zack
Sumit K Chanda
Ren Sun
Genomics Institute of the Novartis Research Foundation · USUniversity of California, Los Angeles · USNational Health Research Institutes · TWUCLA Health · US

Funding

ORF36 Viral Kinase as a Transcriptional Regulator of KSHVP01DE019085 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2008 to 2012
$6.4M
Reactivation of Kaposi's Sarcoma-Associated HerpesvirusR01CA091791 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2001 to 2017
$4.4M
Targeting HIV Reservoirs in vitro and in vivoR01AI070010 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZACK, JEROME A. · 2006 to 2014
$3.7M
Genome-wide identification of suppressors of KSHV reactivationR21CA127042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2007 to 2008
$320k
NCI NIH HHS CA091791NCI NIH HHS CA127042NCI NIH HHS R01 CA091791NCI NIH HHS R21 CA127042NIAID NIH HHS AI070010NIAID NIH HHS R01 AI070010NIDCR NIH HHS DE019085NIDCR NIH HHS P01 DE019085
6 · The paper itself

Abstract

Herpesvirus replication involves the expression of over 80 viral genes in a well ordered sequence, leading to the production of new virions. Viral genes expressed during the earliest phases of replication often regulate both viral and cellular genes. Therefore, they have the potential to bring about dramatic functional changes within the cell. Replication and transcription activator (RTA) is a potent immediate early transcription activator of the gamma-herpesvirus family. This family includes Epstein-Barr virus and Kaposi sarcoma-associated herpesvirus, human pathogens associated with malignancy. Here we combine gene array technology with transcription factor profiling to identify the earliest DNA promoter and cellular transcription factor targets of RTA in the cellular genome. We find that expression of RTA leads to both activation and inhibition of distinct groups of cellular genes. The identity of the target genes suggests that RTA rapidly changes the cellular environment to counteract cell death pathways, support growth factor signaling, and also promote immune evasion of the infected cell. Transcription factor profiling of the target gene promoters highlighted distinct pathways involved in gene activation at specific time points. Most notable throughout was the high level of cAMP-response element-binding protein (CREB)-response elements in RTA target genes. We find that RTA can function as either an activator or an inhibitor of CREB-response genes, depending on the promoter context. The association with CREB also highlights a novel connection and coordination between viral and cellular "immediate early" responses.

Indexed as

Gene Expression RegulationBlotting, WesternCell LineCyclic AMP Response Element-Binding ProteinGammaherpesvirinaeHumansImmediate-Early ProteinsOligonucleotide Array Sequence AnalysisTrans-ActivatorsViral ProteinsCyclic AMP Response Element-Binding ProteinImmediate-Early ProteinsTrans-ActivatorsViral Proteins

Identifiers

PMID20516076
PMCPMC2919076
OpenAlexW2078688652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.